Wave Life Sciences to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
September 10, 2020 16:25 ET
|
Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people...
Vaccinex Reports Second Quarter 2020 Financial Results and Provides Corporate Update
August 14, 2020 08:30 ET
|
Vaccinex, Inc.
On track to report potentially pivotal Phase 2 Huntington’s disease topline data by early October Phase 1/2 trial of pepinemab in Alzheimer’s disease to begin enrolling patients in September Raised...
Wave Life Sciences Reports Second Quarter 2020 Financial Results and Provides Business Update
August 10, 2020 07:30 ET
|
Wave Life Sciences USA, Inc.
Data from 32 mg cohorts of both PRECISION-HD trials and PRECISION-HD OLE trials expected in 1Q 2021 C9orf72 and SNP3 clinical trial applications on track to be submitted in 4Q 2020 ADAR editing...
Wave Life Sciences to Webcast Conference Call of Second Quarter 2020 Financial Results on August 10, 2020
July 27, 2020 16:05 ET
|
Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., July 27, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people...
uniQure Announces First Two Patients Treated in Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
June 19, 2020 07:05 ET
|
uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, June 19, 2020 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...
Wave Life Sciences to Present at the Jefferies 2020 Virtual Healthcare Conference
May 26, 2020 16:05 ET
|
Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., May 26, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people...
Wave Life Sciences Appoints Dr. Ken Rhodes as Senior Vice President, Therapeutics Discovery
May 18, 2020 07:30 ET
|
Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., May 18, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people...
Wave Life Sciences Reports First Quarter 2020 Financial Results and Provides Business Update
May 11, 2020 07:30 ET
|
Wave Life Sciences USA, Inc.
Data from both PRECISION-HD clinical trials expected in 2H 2020 Advancing clinical neurology pipeline − SNP3 and C9orf72 programs on track to initiate clinical development in 2H 2020 First...
Wave Life Sciences to Webcast Conference Call of First Quarter 2020 Financial Results on May 11, 2020
April 29, 2020 16:05 ET
|
Wave Life Sciences USA, Inc.
CAMBRIDGE, Mass., April 29, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people...
uniQure Announces First Quarter 2020 Financial Results and Highlights Recent Company Progress
April 29, 2020 07:00 ET
|
uniQure Inc.
~ Completed Target Patient Dosing in Phase III HOPE-B Trial of Etranacogene Dezaparvovec in Hemophilia B ~ ~ Announced 22 Presentations at Upcoming ASGCT Virtual Annual Meeting ~ LEXINGTON, Mass....